AFT Pharmaceuticals has recently announced for the first time their breakthrough Nasal Drug Delivery Device that they have been developing with IDA and various technology partners. The device is unique in that it can deliver medication to the nasal cavity at a high rate and has a performance far exceeding current market offerings. During the 4 year development program, IDA was responsible for the industrial and mechanical design of the device, design documentation, as well as performing initial scoping studies and proof-of-concept prototyping.

 The device is currently being tooled overseas and is expected to undergo clinical trials shortly. You can read more about the product at: http://www.aftpharm.com/news/new-medical-device-to-help-chronic-sinusitis-sufferers-worldwide/

鼻腔用雾化药物吸入器成功发布

AFT生物制药公司于近日公布了其最新的尖端产品--鼻腔用雾化药物吸入器,该医疗器械由工业设计联盟公司和相关科技提供商共同打造,与众不同的是此款鼻腔药物吸入器可以将雾化药物注入患者鼻腔,所达到的高吸收率远非现有其他产品所能比拟。在为时4年的研发过程中,工业设计联盟公司负责此仪器的的工业设计和机械设计,相关设计文件,进行首期范围界定研究与概念产品的设计和制作等。

该鼻腔药物吸入器目前正在海外进行模具制作,预计近日将通过临床医疗测试,更多该产品信息可于此网站获得:http://www.aftpharm.com/news/new-medical-device-to-help-chronic-sinusitis-sufferers-worldwide/